<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04671576</url>
  </required_header>
  <id_info>
    <org_study_id>NA-101-19</org_study_id>
    <nct_id>NCT04671576</nct_id>
  </id_info>
  <brief_title>Growth and Safety Clinical Trial on a New Infant Formula.</brief_title>
  <official_title>Evaluation of Growth and Safety of Healthy Term Infants Consuming an Organic Formula.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nara Organics</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Paidion Research, Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Nara Organics</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to assess age-appropriate growth of healthy infants fed a new organic&#xD;
      milk-based infant formula.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A 16-weeks length, randomized, controlled, double-blind, parallel study designed to evaluate&#xD;
      growth and tolerance of healthy infants fed milk-based infant formula. The study has been&#xD;
      designed in accordance with Good Clinical Practice guidelines and the requirements of the&#xD;
      Code of Federal Regulations 21 CFR 106.96&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 19, 2021</start_date>
  <completion_date type="Anticipated">July 2, 2022</completion_date>
  <primary_completion_date type="Anticipated">May 2, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>A controlled, decentralized, double-blind trial of healthy, term, formula-fed infants randomized to one of two infant formulas:&#xD;
Control Formula (a standard, commercially available infant formula) or Investigational Formula for 16 weeks.</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Formula intake.</measure>
    <time_frame>Study Day 1 to Study Day 112</time_frame>
    <description>Volume of formula consumed. ml/day</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Weight.</measure>
    <time_frame>Study Day 1 to Study Day 112</time_frame>
    <description>Weight. Weight gain velocity. g and g/day</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Length.</measure>
    <time_frame>Study Day 1 to Study Day 112</time_frame>
    <description>Length. Length gain velocity. cm and cm/day.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Head circumference.</measure>
    <time_frame>Study Day 1 to Study Day 112</time_frame>
    <description>Head circumference. Head circumference gain velocity. cm and cm/day</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Anthropometry Z-scores.</measure>
    <time_frame>Study Day 1 to Study Day 112</time_frame>
    <description>Weight for age Z-score. Length for age Z-score. Weight for length Z-score. Head circumference for age Z-score.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Formula tolerance.</measure>
    <time_frame>Study Day 1 to Study Day 112</time_frame>
    <description>Frequency of adverse events. Fussiness. Inconsolable crying.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gastrointestinal characteristic.</measure>
    <time_frame>Study Day 1 to Study Day 112</time_frame>
    <description>Stool consistency. Stools/day. Regurgitation. Gas.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">160</enrollment>
  <condition>Healthy Growth</condition>
  <arm_group>
    <arm_group_label>Control Formula</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>A standard, milk-based, infant formula.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Investigational Formula</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>An organic milk-based infant formula.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Control Infant Formula</intervention_name>
    <description>Powder, standard commercial infant formula.</description>
    <arm_group_label>Control Formula</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Organic Infant Formula</intervention_name>
    <description>Powder, organic milk-based infant formula.</description>
    <arm_group_label>Investigational Formula</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Healthy gestational term (≥ 37 wks; ≤ 41 wks and 6 days).&#xD;
&#xD;
          -  Birth weight of ≥ 2,500 g and ≤ 4,500 g.&#xD;
&#xD;
          -  Postnatal age ≤ 14 days.&#xD;
&#xD;
          -  Singleton.&#xD;
&#xD;
          -  Designated as healthy, that is no recognized diseases.&#xD;
&#xD;
          -  Weight, length, weight-for-length, and head circumference within ≥ 5th and ≤ 95th&#xD;
             percentile for age-sex according to World Health Organization (WHO) growth standards&#xD;
             (birth to 24 months).&#xD;
&#xD;
          -  Exclusive feeding and tolerating cow milk formula at time of enrollment.&#xD;
&#xD;
          -  Parent(s) or legal guardians are willing and able to feed the assigned formula as sole&#xD;
             source of nutrition.&#xD;
&#xD;
          -  Parent(s) or legal guardians are willing and able to participate in anthropometric&#xD;
             procedures.&#xD;
&#xD;
          -  Parent(s) or legal guardians have voluntarily signed and dated required participation&#xD;
             forms, such as the ICF approved by an IRB.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  An infant from a multiple birth, such as twin, triplet, or the like.&#xD;
&#xD;
          -  Personal or immediate family history of cow-milk protein allergy or intolerance.&#xD;
&#xD;
          -  Currently on any medication to treat growth failure or that may significantly impact&#xD;
             growth.&#xD;
&#xD;
          -  Evidence of any anatomic and/or physiologic condition that would interfere with normal&#xD;
             growth, development, or feeding, such as genetic, neurological, gastrointestinal,&#xD;
             cardiac, pulmonary, hepatic, or renal.&#xD;
&#xD;
          -  A maternal history with known adverse effects on the fetus and/or the newborn infant,&#xD;
             such as positive HIV, insulin-dependent diabetes, opioid exposure during pregnancy.&#xD;
&#xD;
          -  Enrolled in another clinical trial involving a drug, nutrition supplement, device, or&#xD;
             intervention.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>14 Days</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Thomas Young, MD</last_name>
    <role>Study Director</role>
    <affiliation>Paidion Research, Inc.</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Samantha Bostrom, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Telehub Research</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Juan M Gonzalez, PhD</last_name>
    <phone>1-646-389-2527</phone>
    <email>juan@naraorganics.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Esther Hallam</last_name>
    <phone>1-646-389-2527</phone>
    <email>esther@naraorganics.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>TeleResearch Hub</name>
      <address>
        <city>Bountiful</city>
        <state>Utah</state>
        <zip>84010</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Samantha Bostrom, MD</last_name>
      <phone>919-813-6274</phone>
      <phone_ext>203</phone_ext>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>December 11, 2020</study_first_submitted>
  <study_first_submitted_qc>December 11, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 17, 2020</study_first_posted>
  <last_update_submitted>September 8, 2021</last_update_submitted>
  <last_update_submitted_qc>September 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>infant formula</keyword>
  <keyword>cow milk</keyword>
  <keyword>growth</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

